SWE
Toggle navigation
English
Svenska
About Us
The Company
Board & Management
Scientific Advisory Board
Scientific Publications
Events & Mediawatch
Contact Us
Diabetes
Products
Clinical Trials
Investors
Investor Relations
CEO Comments
Corporate Governance
Press Releases
Financial Reports
Skip Navigation Links
Home
»
Investors
»
Press Releases
2021
2020
2019
2018
2017
2016
2015
2014
2013
Former Diamyd Medical
Data pager
Data pager
1
2
Show:
PageSizeComboBox
select
10
20
50
100
150
2 pages
Press Releases
Data pager
Data pager
1
2
Show:
PageSizeComboBox
select
10
20
50
100
150
2 pages
4/9/2021
Fully recruited clinical trial in LADA with Diamyd
®
3/29/2021
Diamyd Medical to present at upcoming scientific conferences
3/25/2021
Diamyd Medical carries out a directed share issue and raises proceeds of SEK 60 million
3/25/2021
Diamyd Medical AB intends to carry out a directed share issue of B-shares
3/25/2021
Quarterly Report II 20/21
3/16/2021
Diamyd Medical selects Cytiva’s FlexFactory platform to make precision medicine type 1 diabetes vaccine
3/4/2021
Update on the design of a Phase III Precision Medicine trial with the Diabetes Vaccine Diamyd
®
2/26/2021
DIAGNODE-2 results and meta-analysis with Diamyd
®
to be presented at diabetes conference
2/22/2021
Diamyd Medical makes an investment in MainlyAI
1/20/2021
Quarterly Report I 20/21
Order GAD for preclinical research
ORDER
©
Privacy Policy
|
Cookie Policy
Share This Page
select
Facebook
Twitter
LinkedIn
Google Plus
Pinterest
Tumblr
StumbleUpon
Blogger
MySpace
Digg
Reddit
Email
GAD PRODUCTS
Order GAD for preclinical research